Impact of mood disturbance, sleep disturbance, fatigue and pain among patients receiving cancer therapy
European Journal of Cancer Care, 07/17/2012
Cheng KKF et al. – The results suggest that mood disturbance, sleep disturbance, fatigue and pain (MSFP) are highly prevalent, whether alone or in combination, in patients receiving cancer therapy, and may negatively influence the patient's functional status and quality of life (QoL) during cancer therapy.



